Nathalie M Delzenne Selected Research

Bile Acids and Salts (Bile Acids)

12/2021	Bile Acid Dysregulation Is Intrinsically Related to Cachexia in Tumor-Bearing Mice.
1/2021	Inflammation-induced cholestasis in cancer cachexia.
1/2020	The nuclear receptor FXR inhibits Glucagon-Like Peptide-1 secretion in response to microbiota-derived Short-Chain Fatty Acids.
1/2017	Hepatocyte MyD88 affects bile acids, gut microbiota and metabolome contributing to regulate glucose and lipid metabolism.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Nathalie M Delzenne Research Topics

Disease

74	Obesity 05/2024 - 04/2005
55	Inflammation (Inflammations) 12/2023 - 05/2006
33	Body Weight (Weight, Body) 05/2024 - 06/2005
18	Insulin Resistance 10/2023 - 11/2005
14	Type 2 Diabetes Mellitus (MODY) 10/2023 - 06/2005
13	Neoplasms (Cancer) 04/2024 - 08/2010
10	Dysbiosis 01/2023 - 12/2009
9	Cachexia 04/2024 - 01/2015
8	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2022 - 11/2005
8	Glucose Intolerance 03/2015 - 09/2007
7	Cardiovascular Diseases (Cardiovascular Disease) 10/2022 - 02/2002
7	Non-alcoholic Fatty Liver Disease 01/2021 - 01/2011
6	Alcoholism (Alcohol Abuse) 06/2022 - 01/2012
6	Overweight 01/2021 - 01/2011
5	Metabolic Diseases (Metabolic Disease) 01/2023 - 01/2009
4	Hypertriglyceridemia 04/2021 - 04/2002
4	Hyperglycemia 01/2012 - 12/2005
4	Endotoxemia 01/2012 - 07/2007
3	Anorexia 01/2023 - 01/2012
2	Acute-Phase Reaction 01/2023 - 01/2021
2	Liver Diseases (Liver Disease) 06/2022 - 01/2019
2	Carcinoma (Carcinomatosis) 12/2021 - 01/2021
2	Weight Loss (Weight Reduction) 12/2020 - 01/2017
2	Hyperphagia (Overeating) 01/2020 - 06/2005
2	Muscular Atrophy (Muscle Atrophy) 10/2018 - 01/2012
2	Fatty Liver 01/2018 - 10/2016
2	Leukemia 01/2015 - 01/2012
2	Hyperinsulinism (Hyperinsulinemia) 01/2012 - 09/2011
2	Shock 12/2007 - 05/2004
1	Acidosis 04/2024
1	Critical Illness (Critically Ill) 12/2023

Drug/Important Bio-Agent (IBA)

36	PrebioticsIBA 10/2023 - 02/2002
30	Glucose (Dextrose)FDA LinkGeneric 10/2023 - 11/2005
19	LipidsIBA 01/2023 - 11/2005
14	Inulin FDA Link 01/2023 - 04/2005
10	LipopolysaccharidesIBA 01/2021 - 04/2002
9	Insulin (Novolin)FDA Link 01/2023 - 04/2005
9	EndocannabinoidsIBA 01/2023 - 07/2010
9	Biomarkers (Surrogate Marker)IBA 01/2022 - 03/2013
9	Glucagon-Like Peptide 1 (GLP 1)IBA 01/2012 - 04/2005
8	Fatty Acids (Saturated Fatty Acids)IBA 04/2024 - 04/2002
8	Dietary Fiber FDA Link 01/2022 - 06/2005
8	CarbohydratesIBA 04/2021 - 08/2006
8	Peptides (Polypeptides)IBA 04/2018 - 04/2005
7	OligosaccharidesIBA 05/2024 - 08/2006
7	CytokinesIBA 01/2023 - 03/2010
7	Messenger RNA (mRNA)IBA 01/2023 - 02/2008
6	Triglycerides (Triacylglycerol)IBA 09/2020 - 06/2005
6	Fructans (Levans)IBA 01/2018 - 04/2005
5	Interleukin-6 (Interleukin 6)IBA 01/2021 - 01/2012
4	CholesterolIBA 01/2023 - 02/2008
4	PolyphenolsIBA 03/2022 - 03/2013
4	EnzymesIBA 01/2022 - 01/2011
4	oligofructoseIBA 01/2022 - 05/2004
4	GlucansIBA 01/2022 - 12/2007
4	Bile Acids and Salts (Bile Acids)IBA 12/2021 - 01/2017
4	IncretinsIBA 01/2020 - 09/2007
4	Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA 10/2016 - 01/2011
4	Proglucagon (Glucagon Precursors)IBA 01/2012 - 08/2006
3	Blood Glucose (Blood Sugar)IBA 10/2023 - 05/2006
3	Proteins (Proteins, Gene)FDA Link 01/2023 - 11/2010
3	Butyrates (Butyrate)IBA 11/2022 - 01/2015
3	ChitinIBA 01/2022 - 10/2019
3	LeptinIBA 01/2021 - 11/2015
3	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 11/2020 - 01/2011
3	1-dodecylpyridoxal (PLD)IBA 01/2020 - 03/2015
3	Glucagon-Like Peptide-1 ReceptorIBA 01/2020 - 05/2006
3	Ethanol (Ethyl Alcohol)IBA 08/2017 - 01/2012
2	AcidsIBA 04/2024 - 01/2012
2	AntioxidantsIBA 12/2023 - 12/2009
2	Sucrose (Saccharose)IBA 01/2023 - 03/2019
2	N-acylethanolaminesIBA 01/2023 - 01/2019
2	Dietary Fats (Dietary Fat)IBA 01/2023 - 01/2019
2	LigandsIBA 01/2023 - 01/2021
2	Leukocyte L1 Antigen Complex (Calgranulin)IBA 01/2022 - 09/2021
2	CurcuminIBA 04/2021 - 01/2013
2	XenobioticsIBA 01/2021 - 12/2020
2	C-Reactive ProteinIBA 01/2021 - 08/2012
2	indoleIBA 01/2021 - 06/2018
2	Conjugated Linoleic AcidsIBA 11/2020 - 01/2018
2	A-factor (Streptomyces)IBA 01/2020 - 08/2011
2	PropionatesIBA 01/2020 - 01/2015
2	Apolipoproteins E (ApoE)IBA 10/2019 - 10/2016
2	phenylacetic acid (phenylacetate)FDA Link 01/2019 - 06/2018
2	Aromatic Amino Acids (Aromatic Amino Acid)IBA 01/2019 - 06/2018
2	EndotoxinsIBA 06/2018 - 03/2011
2	Lipid PeroxidesIBA 02/2012 - 12/2009
2	Nitric Oxide (Nitrogen Monoxide)FDA Link 09/2011 - 02/2011
2	ApelinIBA 09/2011 - 01/2011
1	ProteomeIBA 05/2024
1	2'-fucosyllactoseIBA 05/2024
1	GlucuronidaseIBA 04/2024
1	pHLIP proteinIBA 04/2024
1	Conditioned Culture MediaIBA 04/2024
1	BuffersIBA 04/2024
1	Sodium Bicarbonate (Baking Soda)FDA LinkGeneric 04/2024

Therapy/Procedure

4	Therapeutics 11/2023 - 10/2015
4	Transplantation 01/2021 - 01/2012
2	Drug Therapy (Chemotherapy) 11/2023 - 04/2018
1	Bariatric Surgery 12/2023